Genomic convergence to identify candidate genes for Alzheimer Disease on chromosome 10

A broad region of chromosome 10 (chr10) has engendered continued interest in the etiology of late‐onset Alzheimer Disease (LOAD) from both linkage and candidate gene studies. However, there is a very extensive heterogeneity on chr10. We converged linkage analysis and gene expression data using the concept of genomic convergence that suggests that genes showing positive results across multiple different data types are more likely to be involved in AD. We identified and examined 28 genes on chr10 for association with AD in a Caucasian case‐control dataset of 506 cases and 558 controls with substantial clinical information. The cases were all LOAD (minimum age at onset ≥60 years). Both single marker and haplotypic associations were tested in the overall dataset and 8 subsets defined by age, gender, ApoE and clinical status. PTPLA showed allelic, genotypic and haplotypic association in the overall dataset. SORCS1 was significant in the overall data sets (p=0.0025) and most significant in the female subset (allelic association p=0.00002, a 3‐locus haplotype had p=0.0005). Odds Ratio of SORCS1 in the female subset was 1.7 (p<0.0001). SORCS1 is an interesting candidate gene involved in the Aβ pathway. Therefore, genetic variations in PTPLA and SORCS1 may be associated and have modest effect to the risk of AD by affecting Aβ pathway. The replication of the effect of these genes in different study populations and search for susceptible variants and functional studies of these genes are necessary to get a better understanding of the roles of the genes in Alzheimer disease. 30, 463–471, 2009. © 2008 Wiley‐Liss, Inc.

[1]  C. Haass,et al.  A Structural Switch of Presenilin 1 by Glycogen Synthase Kinase 3β-mediated Phosphorylation Regulates the Interaction with β-Catenin and Its Nuclear Signaling* , 2007, Journal of Biological Chemistry.

[2]  E. Martin,et al.  A test for linkage and association in general pedigrees: the pedigree disequilibrium test. , 2000, American journal of human genetics.

[3]  D. Blacker,et al.  Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.

[4]  H. Schaller,et al.  Identification and characterization of SorCS, a third member of a novel receptor family. , 1999, Biochemical and biophysical research communications.

[5]  J. Hardy,et al.  Alzheimer's disease: the amyloid cascade hypothesis. , 1992, Science.

[6]  B. Crain,et al.  Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. , 1997, Archives of pathology & laboratory medicine.

[7]  Sharon L R Kardia,et al.  Dynamic relationships between the genome and exposures to environments as causes of common human diseases. , 2004, World review of nutrition and dietetics.

[8]  D. Schaid,et al.  Score tests for association between traits and haplotypes when linkage phase is ambiguous. , 2002, American journal of human genetics.

[9]  J. Gilbert,et al.  Effect of heterogeneity on the chromosome 10 risk in late‐onset Alzheimer disease , 2007, Human mutation.

[10]  J C Reed,et al.  Mitochondria and apoptosis. , 1998, Science.

[11]  Patrizia Mecocci,et al.  Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease , 1994, Annals of neurology.

[12]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[13]  Margaret A. Pericak-Vance,et al.  A comparative analysis of the information content in long and short SAGE libraries , 2006, BMC Bioinformatics.

[14]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[15]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[16]  D. Pollen,et al.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease , 1995, Nature.

[17]  S. L. Marques Payão,et al.  Differential Chromosome Sensitivity to 5-Azacytidine in Alzheimer’s Disease , 1998, Gerontology.

[18]  M. Owen,et al.  A full genome scan for late onset Alzheimer's disease , 1999 .

[19]  J. H. Moore,et al.  Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. , 2001, American journal of human genetics.

[20]  A. Hofman,et al.  Frequency and distribution of Alzheimer's disease in Europe: A collaborative study of 1980–1990 prevalence findings , 1991, Annals of neurology.

[21]  H. Schaller,et al.  The three sorCS genes are differentially expressed and regulated by synaptic activity , 2004, Journal of neurochemistry.

[22]  Jonathan L Haines,et al.  Genetics, statistics and human disease: analytical retooling for complexity. , 2004, Trends in genetics : TIG.

[23]  D. Andres,et al.  Analysis of the Complex between Ca2+ Channel β-Subunit and the Rem GTPase* , 2006, Journal of Biological Chemistry.

[24]  Marylyn D. Ritchie,et al.  Multilocus genetic interactions and response to efavirenz-containing regimens: an Adult AIDS Clinical Trials Group study , 2006, Pharmacogenetics and genomics.

[25]  Z. Khachaturian Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[26]  D. Murphy,et al.  Protection against Alzheimer's disease? , 1996, The Lancet.

[27]  P. M. Conneally,et al.  Identification of Novel Genes in Late-Onset Alzheimer's Disease , 2000, Experimental Gerontology.

[28]  Eden Martin,et al.  Genomic convergence: identifying candidate genes for Parkinson's disease by combining serial analysis of gene expression and genetic linkage. , 2003, Human molecular genetics.

[29]  M. Jarema [Advances in the diagnosis of Alzheimer's disease]. , 1990, Wiadomosci lekarskie.

[30]  L. Feuk,et al.  Apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer's disease: finding of a positive association for a polymorphism in the TNFRSF6 gene , 2000, Human Genetics.

[31]  L. Murri,et al.  Causative and susceptibility genes for Alzheimer’s disease: a review , 2003, Brain Research Bulletin.

[32]  R. Holliday DNA methylation and epigenetic mechanisms , 1989, Cell Biophysics.

[33]  J. Haines,et al.  Complete Genomic Screen in Late-Onset Familial Alzheimer’s Disease , 1998, Neurobiology of Aging.

[34]  K. Lunetta,et al.  The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease , 2007, Nature Genetics.

[35]  M. Owen,et al.  Full genome screen for Alzheimer disease: stage II analysis. , 2002, American journal of medical genetics.

[36]  Y. Kim,et al.  Tau overexpression in transgenic mice induces glycogen synthase kinase 3β and β-catenin phosphorylation , 2007, Neuroscience.

[37]  Ji Huang,et al.  [Serial analysis of gene expression]. , 2002, Yi chuan = Hereditas.

[38]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[39]  Margaret A. Pericak-Vance,et al.  SNPselector: a web tool for selecting SNPs for genetic association studies , 2005, Bioinform..

[40]  J. Gilbert,et al.  A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease , 2007, Molecular and Cellular Neuroscience.

[41]  Yaakov Stern,et al.  Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease , 1996, The Lancet.

[42]  Jason H. Moore,et al.  The Ubiquitous Nature of Epistasis in Determining Susceptibility to Common Human Diseases , 2003, Human Heredity.

[43]  Eden R Martin,et al.  Accounting for linkage in family-based tests of association with missing parental genotypes. , 2003, American journal of human genetics.

[44]  M. Albert,et al.  Results of a high-resolution genome screen of 437 Alzheimer's disease families. , 2003, Human molecular genetics.

[45]  G. Zubenko,et al.  A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. , 1998, Genomics.

[46]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[47]  Scott M. Williams,et al.  A balanced accuracy function for epistasis modeling in imbalanced datasets using multifactor dimensionality reduction , 2007, Genetic epidemiology.

[48]  M G McInnis,et al.  Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. , 2000, Science.

[49]  K. Iqbal,et al.  Research advances in Alzheimer's disease and related disorders , 1995 .

[50]  Alison A Motsinger,et al.  Multifactor dimensionality reduction for detecting gene-gene and gene-environment interactions in pharmacogenomics studies. , 2005, Pharmacogenomics.

[51]  J. Poirier,et al.  54-1 Advances in the diagnosis of Alzheimer's disease , 1997, Biological Psychiatry.

[52]  D. Andres,et al.  Analysis of the complex between Ca2+ channel beta-subunit and the Rem GTPase. , 2006, The Journal of biological chemistry.

[53]  G. Schellenberg,et al.  Candidate gene for the chromosome 1 familial Alzheimer's disease locus , 1995, Science.

[54]  E. Kokmen,et al.  Alzheimer's disease and other dementing illnesses in a defined united states population: Incidence rates and clinical features , 1987, Annals of neurology.

[55]  E R Martin,et al.  Genotype‐based association test for general pedigrees: The genotype‐PDT , 2003, Genetic epidemiology.

[56]  K. Campbell,et al.  The Voltage-dependent Calcium Channel β Subunit Contains Two Stable Interacting Domains* , 2003, Journal of Biological Chemistry.

[57]  J. Hall,et al.  Genomic imprinting: review and relevance to human diseases. , 1990, American journal of human genetics.

[58]  Taylor J. Maxwell,et al.  A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease. , 2006, American journal of human genetics.